A Clinical study on Zightudam Qawi Ibtidai ( Grade I Essential Hypertension ) and Comparative Evaluation of Qurs-e- Musakkin with Standard Control Drug Telmisartan in its Managament
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- improvement in following criteria
研究概览
简要总结
Hypertension is the condition in which arterial blood pressure is chronically elevated .the risk of cardiovascular disease such as stroke and CAD is closely related to levels of blood pressure ,to overcome the problem of HTN several classes of antihypertensive drugs have been introduced in modern system of medicine but apart from being effective ,most of these medicines are costly have adverse effects and also they fail to prevent complications of HTN and also cause economic burden on the patients .in ancient unani literature there is description of many drugs ( single and compounds )that have been used for the management of HTN so there is a need to provide efficacious drugs with less side effects for the management of HTN ,keeping in view of above factors it is intented to adopt a study entitled.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 35.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •clinically diagnosed patients of grade 1 essential hypertension (according to WHO/ISH,SBP-139-159 mmhg and DBP 90-99 mmhg on three consecutive visits unfer optimal condition with or without subjective parameters.
- •patients of either sex patients in the age group of 35years to 60 years .
- •no evidence of target organ damage.
- •patients not taking any anti hypertensive drugs prior to state of treatment those who give written consent.
排除标准
- •patients of severe and secondary hypertension.
- •patients of below 35years and above 60 years.
- •pregnant women and lactating mothers.
- •patients with comorbid conditions like liver,kidney,or heart diseases.
- •patients with clinical or laboratory evidence of target organ damage.
- •patients of altered mental status.
- •patients who do not sign informed concent form.
结局指标
主要结局
improvement in following criteria
时间窗: two months with fortnightly follow uo
systolic bp
时间窗: two months with fortnightly follow uo
dystolic bp
时间窗: two months with fortnightly follow uo
次要结局
- improvement in following criteria(headache)
研究者
NAVED AHMAD
Ajmal Khan Tibbiya College
